SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Drug attack shows promise for tough head and neck cancers
Disease control CompletedThis study tested whether combining two FDA-approved cancer drugs, cetuximab and nivolumab, could help people with advanced head and neck cancer that has returned or spread. A total of 95 participants received the drug combination to find the best dose and see if it improves surv…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can less radiation be safer without sacrificing cancer control?
Disease control CompletedThis study tested whether giving lower doses of radiation after surgery for head and neck cancer could reduce long-term side effects like dry mouth and trouble swallowing, while still keeping the cancer from coming back. About 200 patients with certain stages of oral, throat, or …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo therapy aims to stop head and neck cancer return
Disease control CompletedThis phase II trial tested whether adding the targeted drug cetuximab to standard chemotherapy and radiation could help prevent head and neck cancer from coming back after surgery. The study enrolled 53 patients with certain high-risk features. The main goal was to see how many p…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can MRI measurements be trusted for head and neck cancer?
Knowledge-focused CompletedThis study looked at how repeatable and reproducible ADC maps are for measuring head and neck cancer in 58 adults. Participants had MRI scans using a standard method to see if results were consistent across different machines and sessions. The goal was to improve the reliability …
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Sponsor: Regina Elena Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Study tracks swallowing troubles in head and neck cancer patients for 18 months
Knowledge-focused CompletedThis study followed 240 people with head and neck cancer to see how their swallowing changed from diagnosis to 18 months after their first treatment. Researchers used a questionnaire called the Deglutition Handicap Index (DHI) to measure patients' own experience of swallowing pro…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC